Tsilioni Irene
Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Extracell Vesicles Circ Nucl Acids. 2025 Mar 24;6(1):176-179. doi: 10.20517/evcna.2024.96. eCollection 2025.
Mast cells (MCs) play a crucial role in immune responses by storing and releasing inflammatory mediators from secretory granules (SGs). The biogenesis, maturation, and fusion of these granules with the plasma membrane regulate inflammation, immune cell recruitment, and tissue homeostasis. However, the exact mechanism underlying this process remains unclear. Recent studies have identified a novel mechanism of SG fusion involving amphisomes, hybrid organelles formed by the fusion of late endosomes and autophagosomes. This process not only facilitates SG enlargement but also promotes the release of exosomes, small vesicles crucial for intercellular communication and immune modulation. In particular, Omari delve into the molecular machinery governing amphisome formation and SG fusion, focusing on key players such as Rab5, PTPN9, CD63, and phosphoinositides (PIs). They propose a dynamic model wherein amphisomes act as intermediates in SG maturation, promoting homotypic fusion events that regulate SG content and size. A critical aspect of this process is the lipid signaling cascade, particularly involving PI4K and CD63, which coordinates SG fusion and exosome release. These findings challenge the conventional view of SGs as static storage compartments, positioning them as dynamic hubs of vesicle trafficking and secretion. By elucidating the role of amphisomes and lipid signaling in SG biology, this study offers a significant shift in understanding and introduces new concepts that could drive future research. This commentary, while endorsing the authors' key conclusions, also highlights important questions regarding the functional implications of these novel mechanisms and their potential therapeutic applications.
肥大细胞(MCs)通过从分泌颗粒(SGs)储存和释放炎症介质,在免疫反应中发挥关键作用。这些颗粒的生物发生、成熟以及与质膜的融合调节炎症、免疫细胞募集和组织稳态。然而,这一过程背后的确切机制仍不清楚。最近的研究确定了一种涉及双泡体的SG融合新机制,双泡体是由晚期内体和自噬体融合形成的混合细胞器。这一过程不仅促进了SG的扩大,还促进了外泌体的释放,外泌体是对细胞间通讯和免疫调节至关重要的小囊泡。特别是,奥马里深入研究了控制双泡体形成和SG融合的分子机制,重点关注Rab5、PTPN9、CD63和磷酸肌醇(PIs)等关键分子。他们提出了一个动态模型,其中双泡体在SG成熟过程中充当中间体,促进调节SG内容物和大小的同型融合事件。这一过程的一个关键方面是脂质信号级联反应,特别是涉及PI4K和CD63的反应,它协调SG融合和外泌体释放。这些发现挑战了将SGs视为静态储存区室的传统观点,将它们定位为囊泡运输和分泌的动态中心。通过阐明双泡体和脂质信号在SG生物学中的作用,这项研究在理解上带来了重大转变,并引入了可能推动未来研究的新概念。这篇评论在赞同作者主要结论的同时,也强调了关于这些新机制的功能影响及其潜在治疗应用的重要问题。